SCHEMBL23745489

SCHEMBL23745489

Clc1ccc(Oc2cccc(CNCCc3c[nH]c4ccccc34)c2)cc1

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.71
MC5R P33032 2/20 0.60
MC3R P41968 2/20 0.60
MC1R Q01726 2/20 0.60
HTR2A P28223 2/20 0.58
MEN1 O00255 2/20 0.53
HTR6 P50406 2/20 0.53
LMNA P02545 2/20 0.53
TP53 P04637 1/20 0.53
MAPT P10636 3/20 0.52
MAPK1 P28482 1/20 0.52
SNCA P37840 3/20 0.52
LTA4H P09960 1/20 0.51
PLA2G2A P14555 1/20 0.51
ALDH1A1 P00352 1/20 0.50
POLB P06746 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23722135 0.99 KMT2A (0.70) KMT2AMC5RMC3RMC1RHTR2A
SCHEMBL5947571 0.92 KMT2A (0.79) KMT2AMC5RMC3RMC1RHTR2A
SCHEMBL5947200 0.89 SNCA (0.64) KMT2AMC5RMC3RMC1RHTR2A
SCHEMBL5948004 0.89 KMT2A (0.62) KMT2AMC5RMC3RMC1RHTR2A
SCHEMBL5948017 0.89 KMT2A (0.71) KMT2AMC5RMC3RMC1RHTR2A
SCHEMBL5947148 0.88 MC5R (0.75) KMT2AMC5RMC3RMC1RHTR2A
SCHEMBL5947375 0.87 KMT2A (0.71) KMT2AMC5RMC3RMC1RHTR2A
SCHEMBL2534484 0.87 HTR2A (0.71) KMT2AHTR2ALTA4HPLA2G2APOLB
SCHEMBL5947524 0.87 KMT2A (0.70) KMT2AMC5RMC3RMC1RHTR2A
SCHEMBL5947705 0.86 KMT2A (0.72) KMT2AMC5RMC3RMC1RHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 KMT2A 4684/4885MC5R 3934/4885MC3R 4252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.